News Headline Summary

Synergy Pharmaceuticals (SYGP) price target raised to USD 13 from USD 7 at Cantor Fitzgerald

Reaction details (19:38)

- Co. shares are unmoved in reaction to the news; trades USD 6.00 (+14.07%) last.

Analysis details (19:58)

- Earlier today, the Co. announced their drug Plecanatide met the primary and secondary endpoints of a Phase IIb/III clinical study, hence company shares seen trading up over 14% last.

02 Jan 2013 - 19:36 - Equities - Source: Newswires

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: